![]() |
Indiana Administrative Code (Last Updated: December 20, 2016) |
![]() |
Title 410. INDIANA STATE DEPARTMENT OF HEALTH |
![]() |
Article 410IAC1. COMMUNICABLE DISEASE CONTROL |
![]() |
Rule 410IAC1-2.5. Disease Reporting and Control |
Section 410IAC1-2.5-75. Reporting requirements for physicians and hospital administrators
-
(a) It shall be the duty of each:
(1) physician licensed under IC 25-22.5; and
(2) administrator of a hospital licensed under IC 16-21, or the administrator's representative;
to report all cases and suspected cases of the diseases listed in subsection (d). Reporting of specimen results by a laboratory to health officials does not nullify the physician's or administrator's obligations to report the case.
(b) Except for HIV infection/disease, the report required by subsection (a) shall be made to the local health officer in whose jurisdiction the patient normally resides or, in the absence of such information, in whose jurisdiction the patient was examined at the time the diagnosis was made or suspected. If the patient is a resident of a different jurisdiction, the local health jurisdiction receiving the report shall forward the report to the local health jurisdiction where the patient resides. If the patient is not a resident of Indiana, the report shall be forwarded to the department. If a person who is required to report is unable to make a report to the local health officer within the time mandated by this rule, a report shall be made directly to the department within the time mandated by this rule. The report for HIV infection/disease shall be made directly to the department in accordance with IC 16-41-2-3.
(c) Any reports of diseases required by subsection (a) shall include the following:
(1) The patient's:
(A) full name;
(B) street address;
(C) city;
(D) zip code;
(E) county of residence;
(F) telephone number;
(G) date of birth or age if date of birth is not available;
(H) sex; and
(I) race and ethnicity, if available.
(2) The date of onset.
(3) The diagnosis.
(4) Definitive diagnostic test results, for example:
(A) culture;
(B) IgM;
(C) liver enzyme levels;
(D) serology;
(E) Western blot;
(F) interferon gamma release assay;
(G) NAAT; or
(H) tuberculin skin test.
(5) The:
(A) name;
(B) address; and
(C) telephone number;
of the attending physician.
(6) Other epidemiologically necessary information requested by the:
(A) local health officer;
(B) state designated districts; or
(C) commissioner.
(7) Persons who are tested anonymously at a counseling and testing site cannot be reported using personal identifiers. Rather, they are to be reported using a numeric identifier code. The following shall also be reported:
(A) Age.
(B) Race.
(C) Sex.
(D) Risk factors.
(E) County of residence.
(8) The:
(A) name;
(B) address; and
(C) telephone number;
of the person completing report.
(d) The dangerous communicable diseases and conditions described in this subsection shall be reported within the time specified. Diseases or conditions that are to be reported immediately shall be reported by telephone or other instantaneous means of communication on first knowledge or suspicion of the diagnosis. Diseases that are to be reported within twenty-four (24) hours, seventy-two (72) hours, or five (5) business days shall be reported within twenty-four (24) hours, seventy-two (72) hours, or five (5) business days of first knowledge or suspicion of the diagnosis by telephone, electronic data transfer, other confidential means of communication, or official report forms furnished by the department. During evening, weekend, and holiday hours, those required to report to the local health department should report diseases required to be immediately reported to the after-hours duty officer at the local health department. HIV infection/disease required to be reported to the department during evening, weekend, and holiday hours should be reported immediately to the after-hours duty officer at the department at (317) 233-1325. If unable to contact the after-hours duty officer locally, or one has not been designated locally, those required to report shall file their reports with the after-hours duty officer at the department at (317) 233-1325.
DANGEROUS COMMUNICABLE DISEASES AND CONDITIONS
Disease
When to Report (from probable diagnosis)
Disease Intervention Methods (section of this rule)
Acquired immunodeficiency syndrome
See HIV Infection/Disease
Sec. 109
Anaplasmosis
Within 72 hours
Sec. 96
Animal bites
Within 24 hours
Sec. 80
Anthrax
Immediately
Sec. 81
Arboviral disease (non-neuroinvasive or neuroinvasive) (including, but not limited to, dengue, chikungunya, EEE, Japanese encephalitis, La Crosse/California serogroup viruses, Powassan, SLE, WEE, and West Nile virus)
Immediately
Sec. 82
Babesiosis
Within 72 hours
Sec. 83
Botulism
Immediately
Sec. 84
Brucellosis
Immediately
Sec. 85
Campylobacteriosis
Within 72 hours
Sec. 86
Carbapenemase-producing carbapenem-resistant Enterobacteriaceae (CP-CRE)
Within 72 hours
Sec. 87
Chancroid
Within 72 hours
Sec. 88
Chikungunya virus
Immediately
Sec. 82
Chlamydia trachomatis, genital infection
Within 72 hours
Sec. 89
Cholera
Immediately
Sec. 90
Coccidioidomycosis
Within 72 hours
Sec. 91
Cryptosporidiosis
Within 72 hours
Sec. 92
Cyclosporiasis
Within 72 hours
Sec. 93
Cysticercosis (Neurocysticercosis)
Within 72 hours
Sec. 94
Diphtheria
Immediately
Sec. 95
Dengue
Immediately
Sec. 82
Eastern equine encephalitis (EEE)
Immediately
Sec. 82
Ehrlichiosis
Within 72 hours
Sec. 96
Escherichia coli (E. coli) infection (Shiga toxin-producing (STEC)), including, but not limited to, E. coli 0157, E. coli 0157:H7, non-0157 E. coli, and Shiga toxin detected
Immediately
Sec. 97
Giardiasis
Within 72 hours
Sec. 98
Gonorrhea
Within 72 hours
Sec. 99
Granuloma inguinale
Within 72 hours
Sec. 100
Haemophilus influenzae invasive disease, and antimicrobial susceptibility testing*
Within 24 hours
Sec. 101
Hansen's disease (leprosy)
Within 72 hours
Sec. 102
Hantavirus pulmonary syndrome
Immediately
Sec. 103
Hemolytic uremic syndrome, postdiarrheal
Immediately
Sec. 97
Hepatitis, viral, type A
Immediately
Sec. 104
Hepatitis, viral, type B
Within 72 hours
Sec. 105
Hepatitis, viral, type B, pregnant woman (acute and chronic), or perinatally exposed infant
Immediately (when discovered at or close to time of birth)
Sec. 105
Hepatitis, viral, type C (acute)
Within five (5) business days
Sec. 106
Hepatitis, viral, type delta
Within 72 hours
Sec. 105
Hepatitis, viral, type E
Immediately
Sec. 107
Hepatitis, viral, unspecified
Within 72 hours
Histoplasma capsulatum
Within 72 hours
Sec. 108
HIV infection/disease
Within 72 hours after informing patient or if patient does not return for test results
Sec. 109
HIV infection/disease, pregnant woman, or perinatally exposed infant
Immediately (when discovered at or close to time of birth)
Sec. 109
Influenza-associated death
Within 72 hours
Sec. 110
Japanese encephalitis
Immediately
Sec. 82
La Crosse encephalitis (California serogroup viruses)
Immediately
Sec. 82
Latent tuberculosis infection
Within five (5) business days
Sec. 111
Legionellosis
Within 72 hours
Sec. 112
Leptospirosis
Within 72 hours
Sec. 113
Listeriosis
Within 72 hours
Sec. 114
Lyme disease
Within 72 hours
Sec. 115
Lymphogranuloma venereum
Within 72 hours
Sec. 116
Malaria
Within 72 hours
Sec. 117
Measles (rubeola)
Immediately
Sec. 118
Meningococcal, invasive disease
Immediately
Sec. 119
Mumps
Within 24 hours
Sec. 120
Novel influenza A
Within 24 hours
Sec. 121
Pertussis
Within 24 hours
Sec. 122
Plague
Immediately
Sec. 123
Poliomyelitis
Immediately
Sec. 124
Powassan
Immediately
Sec. 82
Psittacosis
Within 72 hours
Sec. 125
Q fever
Immediately
Sec. 126
Rabies in humans or animals (confirmed and suspect animal with human exposure)
Immediately
Sec. 127
Rabies, postexposure treatment
Within 72 hours
Secs. 127 and 80
Rocky Mountain spotted fever
Within 72 hours
Sec. 128
Rubella (German measles)
Immediately
Sec. 129
Rubella congenital syndrome
Immediately
Sec. 129
Salmonellosis, nontyphoidal
Within 72 hours
Sec. 130
Salmonellosis and antimicrobial susceptibility testing*
Within 72 hours
Sec. 130
Shigellosis and antimicrobial susceptibility testing*
Immediately
Sec. 131
Smallpox (variola infection)
Immediately
Sec. 132
Adverse events or complications due to smallpox vaccination (vaccinia virus infection) or secondary transmission to others after vaccination. This includes accidental implantation at sites other than the vaccination site, secondary bacterial infections at vaccination site, vaccinia keratitis, eczema vaccinatum, generalized vaccinia, congenital vaccinia, progressive vaccinia, vaccinia encephalitis, death due to vaccinia complications, and other complications requiring significant medical intervention.
Immediately
Sec. 132
St. Louis encephalitis (SLE)
Immediately
Sec. 82
Staphylococcus aureus, vancomycin resistance level of MIC ≥ 8 μg/mL, or severe Staphylococcus aureus in a previously healthy person
Within 72 hours
Sec. 133
Streptococcus pneumoniae, invasive disease and antimicrobial susceptibility testing*
Within 72 hours
Sec. 134
Streptococcus, group A, invasive disease
Within 72 hours
Sec. 135
Syphilis
Within 72 hours
Sec. 136
Taenia solium infection
Within 72 hours
Sec. 137
Tetanus
Within 72 hours
Sec. 138
Toxic shock syndrome (streptococcal or staphylococcal)
Within 72 hours
Sec. 139
Trichinosis
Within 72 hours
Sec. 140
Tuberculosis disease, cases and suspects
Within 24 hours
Sec. 141
Tularemia
Immediately
Sec. 142
Typhoid and paratyphoid fever, cases and carriers, and antimicrobial susceptibility testing*
Immediately
Sec. 143
Typhus, endemic (fleaborne)
Within 72 hours
Sec. 144
Varicella (chickenpox)
Within 72 hours
Sec. 145
Vibriosis (non-cholera)
Within 72 hours
Sec. 146
West Nile virus (WNV)
Immediately
Sec. 82
Western equine encephalitis (WEE)
Immediately
Sec. 82
Yellow fever
Immediately
Sec. 147
Yersiniosis
Within 72 hours
Sec. 148
*Reporting of disease is required to follow the "When to Report (from probable diagnosis)" time frame, and the antimicrobial susceptibility testing results are to be reported as soon as they become available.
(e) Reporting of HIV infection/disease shall include classification as defined in the CDC Morbidity and Mortality Weekly Report Volume 63, No. RR-03, April 11, 2014. Supplemental reports shall be provided by the physician when an individual's classification changes. The CD4+ T-lymphocyte count and percentage or viral load count, or both, shall be included with both initial and supplemental reports.
(f) The department, under the authority of IC 4-22-2-37.1, may adopt emergency rules to include mandatory reporting of emerging infectious diseases. Reports shall include the information specified in subsection (c).
(g) Outbreaks of any of the following shall be reported immediately upon suspicion:
(1) Any disease required to be reported under this section.
(2) Diarrhea of the newborn (in hospitals or other institutions).
(3) Foodborne or waterborne diseases in addition to those specified by name in this rule.
(4) Streptococcal illnesses.
(5) Conjunctivitis.
(6) Impetigo.
(7) Nosocomial disease within hospitals and health care facilities.
(8) Influenza-like illness.
(9) Viral meningitis.
(10) Unusual occurrence of disease.
(11) Any disease, including, but not limited to:
(A) anthrax;
(B) plague;
(C) tularemia;
(D) Brucella species;
(E) smallpox;
(F) botulism; or
(G) multiple drug-resistant tuberculosis.
(12) Chemical illness that is considered:
(A) a bioterrorism threat;
(B) an importation; or
(C) a laboratory release.
(h) Failure to report constitutes a Class A infraction as specified by IC 16-41-2-8. (Indiana State Department of Health; 410 IAC 1-2.5-75; filed Nov 25, 2015, 2:54 p.m.: 20151223-IR-410150039FRA)